On Monday, Synopsys earned a positive adjustment to its Relative Strength (RS) Rating, from 64 to 75.
How To Invest In Stocks In Both Bull And Bear Markets
IBD's unique rating measures share price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best-performing stocks often have an RS Rating north of 80 in the early stages of their moves. See if Synopsys can continue to show renewed price strength and clear that threshold.
Synopsys is not currently near a potential buy zone. See if the stock goes on to form a sound pattern that could launch a new move.
Earnings grew 22% last quarter, up from -10% in the prior report. Revenue also increased, from -4% to 10%.
The company earns the No. 4 rank among its peers in the Computer Software-Design industry group. Autodesk is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
